MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 70 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $548,000 | +0.9% | 714,946 | +1.9% | 0.00% | 0.0% |
| Q2 2020 | $543,000 | +12.9% | 701,946 | -12.5% | 0.00% | 0.0% |
| Q1 2020 | $481,000 | -73.3% | 801,946 | +0.9% | 0.00% | -66.7% |
| Q4 2019 | $1,804,000 | +284.6% | 794,746 | +6.9% | 0.01% | +200.0% |
| Q3 2019 | $469,000 | -28.8% | 743,746 | -3.4% | 0.00% | -33.3% |
| Q2 2019 | $659,000 | -21.7% | 769,670 | -0.4% | 0.00% | 0.0% |
| Q1 2019 | $842,000 | +72.5% | 772,895 | -5.8% | 0.00% | 0.0% |
| Q4 2018 | $488,000 | -49.4% | 820,895 | -21.7% | 0.00% | -25.0% |
| Q3 2018 | $964,000 | +185.2% | 1,048,092 | +34.6% | 0.00% | +100.0% |
| Q2 2018 | $338,000 | -33.6% | 778,520 | +17.0% | 0.00% | -33.3% |
| Q1 2018 | $509,000 | -33.5% | 665,120 | +0.8% | 0.00% | -40.0% |
| Q4 2017 | $765,000 | -13.3% | 659,890 | -1.3% | 0.01% | -16.7% |
| Q3 2017 | $882,000 | -19.4% | 668,390 | +3.2% | 0.01% | -25.0% |
| Q2 2017 | $1,094,000 | -38.6% | 647,366 | +0.7% | 0.01% | -42.9% |
| Q1 2017 | $1,781,000 | – | 643,066 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
| Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
| IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
| Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
| Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
| BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
| Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |